Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
Creator
Miorin, Lisa
García-Sastre, Adolfo
Krammer, Florian
Martinez-Sobrido, Luis
Simon, Viviana
Liu, Wen-Chun
Moran, Thomas
Albrecht, Randy
White, Kris
Amanat, Fatima
Mcmahon, Meagan
Meade, Philip
Strohmeier, Shirin
source
Medline; PMC
abstract
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged in the city of Wuhan, Hubei Province, China, in late 2019. Since then, the virus has spread globally and caused a pandemic. Assays that can measure the antiviral activity of antibodies or antiviral compounds are needed for SARS‐CoV‐2 vaccine and drug development. Here, we describe in detail a microneutralization assay, which can be used to assess in a quantitative manner if antibodies or drugs can block entry and/or replication of SARS‐CoV‐2 in vitro. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Microneutralization assay to test inhibition of virus by antibodies (purified antibodies or serum/plasma) Basic Protocol 2: Screening of anti‐SARS‐CoV‐2 compounds in vitro Support Protocol: SARS‐CoV‐2 propagation
has issue date
2020-06-25
(
xsd:dateTime
)
bibo:doi
10.1002/cpmc.108
bibo:pmid
32585083
has license
no-cc
sha1sum (hex)
caa91a7e09a2d3b7cf7bd719e86deb186f748ccd
schema:url
https://doi.org/10.1002/cpmc.108
resource representing a document's title
An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
has PubMed Central identifier
PMC7361222
has PubMed identifier
32585083
schema:publication
Curr Protoc Microbiol
resource representing a document's body
covid:caa91a7e09a2d3b7cf7bd719e86deb186f748ccd#body_text
is
schema:about
of
named entity 'SARS-CoV-2'
named entity 'antiviral activity'
named entity 'coronavirus'
named entity 'infection'
named entity 'MTT assay'
named entity 'cytotoxic'
named entity 'SARS-CoV-2'
named entity 'growth medium'
named entity 'cell line'
named entity 'China'
named entity 'BSL-2'
named entity 'severe acute respiratory syndrome coronavirus 2'
named entity 'antibodies'
named entity 'MTT assay'
named entity 'SARS-CoV-2'
named entity 'antibody'
named entity 'coronaviruses'
named entity 'DMSO'
named entity 'infection'
named entity 'data analysis'
named entity 'supernatants'
named entity 'human population'
named entity 'Positive and negative controls'
named entity 'virus'
named entity 'biosafety cabinet'
named entity 'infection'
named entity 'BSL-3'
named entity 'Microplate Reader'
named entity 'Non-linear regression'
named entity 'virus'
named entity 'DAPI'
named entity 'MTT assay'
named entity 'reagent'
named entity 'cell lines'
named entity 'cytotoxicity'
named entity '96-well plate'
named entity 'antiviral activity'
named entity 'cell culture'
named entity 'cell death'
named entity 'neutralizing antibodies'
named entity 'nucleoprotein'
named entity 'virus'
named entity 'positive and negative controls'
named entity 'antivirals'
named entity 'cell culture'
named entity 'infection'
named entity 'virus'
named entity '37°C'
named entity 'SARS-CoV2'
named entity 'cytotoxic'
named entity 'antibody'
named entity 'microneutralization'
named entity 'DMEM'
named entity 'plaque assay'
named entity 'toxicity'
named entity 'Microbiology'
named entity '96-well plate'
named entity 'cell lines'
named entity 'Krammer'
named entity 'immunostaining'
named entity 'viral replication'
named entity 'cell line'
named entity '2-phenylindole'
named entity 'cytometer'
named entity 'formaldehyde'
named entity 'antiviral'
named entity 'immunostain'
named entity 'Incubate'
named entity 'Incubate'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software